E-LIB Suche - Ergebnisse für: Sofen, H.

1

Three‐year efficacy and safety of certolizumab pegol for th..:

Warren, R. B. ; Lebwohl, M. ; Sofen, H....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 12 - p. 2398-2408 , 2021

Link: https://doi.org/10.1111/..

2

Efficacy and safety of apremilast in patients with moderate..:

Van Voorhees, A.S. ; Stein Gold, L. ; Lebwohl, M....
British Journal of Dermatology. 185 (2021) 4 - p. 840-842 , 2021

Link: https://doi.org/10.1111/..

3

Dose Adjustment Patterns in the Open-Label Extension Arms o..:

Blauvelt, A ; Gottlieb, AB ; Fierens, F...
SKIN The Journal of Cutaneous Medicine. 4 (2020) 6 - p. s85 , 2020

Link: https://doi.org/10.25251..

4

ASN002 demonstrates efficacy and improves inflammation in A:

Bissonnette, R. ; Maari, C. ; Forman, S....
British Journal of Dermatology. 181 (2019) 4 - p. , 2019

Link: https://doi.org/10.1111/..

5

Incidence of serious gastrointestinal events among tildraki..:

Gooderham, M. ; Elewski, B.E. ; Pariser, D.M....
Journal of the European Academy of Dermatology and Venereology. 33 (2019) 10 - p. , 2019

Link: https://doi.org/10.1111/..

6

Efficacité du certolizumab pegol en retraitement du psorias..:

Khemis, A. ; Lebwohl, M. ; Piguet, V....
Annales de Dermatologie et de Vénéréologie. 146 (2019) 12 - p. A340-A341 , 2019

Link: https://doi.org/10.1016/..

7

The Efficacy of Certolizumab Pegol Re-Treatment on Plaque P..:

Lebwohl, M ; Piguet, V ; Sofen, H.
SKIN The Journal of Cutaneous Medicine. 3 (2019) 2 - p. 174 , 2019

Link: https://doi.org/10.25251..

8

Tildrakizumab efficacy and impact on quality of life up to ..:

Blauvelt, A. ; Sofen, H. ; Papp, K....
Journal of the European Academy of Dermatology and Venereology. 33 (2019) 12 - p. 2305-2312 , 2019

Link: https://doi.org/10.1111/..

9

A reliability study using Network Oriented Research Assista..:

Jeong, D. ; Aralis, H. ; Bruhn, K.W....
British Journal of Dermatology. 181 (2019) 1 - p. 214-215 , 2019

Link: https://doi.org/10.1111/..

10

The oral Janus kinase/spleen tyrosine kinase inhibitorASN00..:

Bissonnette, R. ; Maari, C. ; Forman, S....
British Journal of Dermatology. 181 (2019) 4 - p. 733-742 , 2019

Link: https://doi.org/10.1111/..

11

ASN002 证明有疗效并可改善AD 炎症:

Bissonnette, R. ; Maari, C. ; Forman, S....
British Journal of Dermatology. 181 (2019) 4 - p. , 2019

Link: https://doi.org/10.1111/..

12

Maintien de la réponse chez des patients souffrant de psori..:

Augustin, M. ; Węgłowska, J. ; Lebwohl, M....
Annales de Dermatologie et de Vénéréologie. 145 (2018) 12 - p. S354-S355 , 2018

Link: https://doi.org/10.1016/..

13

Efficacité du certolizumab pégol chez des patients souffran..:

Hegazy, S. ; Augustin, M. ; Węgłowska, J....
Annales de Dermatologie et de Vénéréologie. 145 (2018) 12 - p. S351-S352 , 2018

Link: https://doi.org/10.1016/..

14

Durability of Response in Patients with Chronic Plaque Psor..:

Augustin, M ; Wegtowska, J ; Lebwohl, M...
SKIN The Journal of Cutaneous Medicine. 2 (2018) - p. S87 , 2018

Link: https://doi.org/10.25251..

15

Clinical Response in Plaque Psoriasis Patients Switching fr..:

Augustin, M ; Wegtowska, J ; Lebwohl, M...
SKIN The Journal of Cutaneous Medicine. 2 (2018) - p. S86 , 2018

Link: https://doi.org/10.25251..